Boule Diagnostics AB Stock OTC Markets
Equities
BDABF
SE0011231158
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 USD | -36.77% | -.--% | -.--% |
05-08 | Boule Diagnostics AB Appoints Rikke Rytter as Director | CI |
05-07 | Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024 |
Sales 2024 * | 579M 55.66M 76.5M | Sales 2025 * | 609M 58.54M 80.46M | Capitalization | 427M 41.06M 56.44M |
---|---|---|---|---|---|
Net income 2024 * | 35M 3.36M 4.62M | Net income 2025 * | 43M 4.13M 5.68M | EV / Sales 2024 * | 0.82 x |
Net Debt 2024 * | 47.3M 4.55M 6.25M | Net Debt 2025 * | 40.53M 3.9M 5.35M | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
12.1
x | P/E ratio 2025 * |
9.73
x | Employees | 200 |
Yield 2024 * |
2.14% | Yield 2025 * |
3.14% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | -36.77% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 12-31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.46% | 220B | |
+14.38% | 196B | |
+26.90% | 152B | |
+33.90% | 114B | |
+4.45% | 66.49B | |
+15.11% | 52.89B | |
+1.93% | 49.48B | |
-4.22% | 38.85B | |
-1.75% | 34.68B |
- Stock Market
- Equities
- BOUL Stock
- BDABF Stock